Details for Patent: 9,765,053
✉ Email this page to a colleague
Summary for Patent: 9,765,053
Title: | Methods of treatment using selective 5-HT2A inverse agonists |
Abstract: | Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is administered to a patient in need of such treatment. |
Inventor(s): | Andersson; Carl-Magnus A. (Glostrup, DK), Croston; Glenn (San Diego, CA), Hansen; Eva Louise (Glostrup, DK), Uldam; Allan Kjaersgaard (Glostrup, DK) |
Assignee: | ACADIA Pharmaceuticals Inc. (San Diego, CA) |
Application Number: | 13/053,079 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,765,053 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,765,053
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,765,053
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 348808 | ⤷ Sign Up | |||
Australia | 2005202257 | ⤷ Sign Up | |||
Australia | 4007201 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |